Pushing Antibody Potential Further.
We develop and optimise high-quality monoclonal antibodies, supporting your journey from discovery to clinical trials with rigorous processes and advanced cell line testing.
Optimising Cell Lines for Quality Output.
Our cell line testing and optimisation process ensures robust growth and high-quality antibody production. Using the “1 cell per well” method in 96-well plates, we systematically evaluate each hybridoma over 2–3 weeks for both growth and sustained output. Only the strongest, most productive clones advance to the next stage—guaranteeing exceptional results in every batch.
Rigorous Validation.
Our rigorous validation and equipment qualification processes guarantee reliable, compliant production—ensuring every batch meets the highest quality standards for clinical applications.
Secure Cell Banking & Storage.
We provide secure, dual-site liquid nitrogen cell banking for primary and secondary lines. Comprehensive QC testing ensures viability, purity, and productivity—safeguarding your vital resources and maintaining the highest standards for long-term storage.
QC testing of cell banks includes:
– Checking number of cells
– % viability
– Isotype
– % producing cells
– Infection-free status
Curida also receives customer cells for storage and offers production of improved cell banks.
Advance Your Biologics with Confidence.
Get in touch to see how we can support your biologics journey — from antibody or diagnostics development through to clinical manufacturing and supply.